Jefferies Group's EW Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 25,589 shares of Edwards Lifesciences Corporation (EW) worth $2.18 M, representing 0.01% of the portfolio. First purchased in 2023-Q1, this medium-term investment has been held for 12 quarters.
Based on 13F filings, Jefferies Group has maintained a strategic position in EW, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2023, adding 171,304 shares. Largest reduction occurred in Q2 2024, reducing 69,087 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Edwards Lifesciences Corporation (EW) Holding Value Over Time
Track share changes against reported price movement
Quarterly Edwards Lifesciences Corporation (EW) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -26,911 | Reduce 51.26% | 25,589 | $85.25 |
| Q3 2025 | +52,500 | New Buy | 52,500 | $77.77 |
| Q2 2025 | -41,969 | Sold Out | 0 | $0.00 |
| Q1 2025 | -8,769 | Reduce 17.28% | 41,969 | $72.48 |
| Q4 2024 | -40,964 | Reduce 44.67% | 50,738 | $74.03 |
| Q3 2024 | +51,202 | Add 126.42% | 91,702 | $65.99 |
| Q2 2024 | -69,087 | Reduce 63.04% | 40,500 | $92.37 |
| Q1 2024 | -68,726 | Reduce 38.54% | 109,587 | $95.56 |
| Q4 2023 | +171,304 | Add 2444.06% | 178,313 | $76.25 |
| Q3 2023 | +4,790 | Add 215.86% | 7,009 | $69.28 |
| Q2 2023 | -44,481 | Reduce 95.25% | 2,219 | $94.33 |
| Q1 2023 | +46,700 | New Buy | 46,700 | $82.73 |
Jefferies Group's Edwards Lifesciences Corporation Investment FAQs
Jefferies Group first purchased Edwards Lifesciences Corporation (EW) in Q1 2023, acquiring 46,700 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Edwards Lifesciences Corporation (EW) for 12 quarters since Q1 2023.
Jefferies Group's largest addition to Edwards Lifesciences Corporation (EW) was in Q4 2023, adding 178,313 shares worth $13.6 M.
According to the latest 13F filing for Q4 2025, Jefferies Group's firm, Jefferies Financial Group Inc., owns 25,589 shares of Edwards Lifesciences Corporation (EW), valued at approximately $2.18 M.
As of the Q4 2025 filing, Edwards Lifesciences Corporation (EW) represents approximately 0.01% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in Edwards Lifesciences Corporation (EW) was 178,313 shares, as reported at the end of Q4 2023.